Startseite Clinical characteristics, surgical approach, BRAFV600E mutation and sodium iodine symporter expression in pediatric patients with thyroid carcinoma
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Clinical characteristics, surgical approach, BRAFV600E mutation and sodium iodine symporter expression in pediatric patients with thyroid carcinoma

  • Paula Castro EMAIL logo , Esteban Patiño , Fernando Fierro , Carolina Rojas , Giancarlo Buitrago und Natalia Olaya
Veröffentlicht/Copyright: 8. Oktober 2020

Abstract

Objectives

Thyroid cancer is the most common endocrine neoplasm in childhood. There are few studies characterizing pediatric population in Colombia. We intend to detail the clinical, histological characteristics, BRAFV600E mutational status and NIS (sodium-iodine symporter) expression of children with papillary thyroid carcinoma (PTC) managed at Hospital de La Misericordia.

Methods

Medical records of the Department of Pediatric Surgery and Pathology from 2009 to 2018 were scrutinized in search of cases of differentiated thyroid carcinoma. A descriptive analysis was made. Paraffin embedded tumoral tissue was recovered to assess BRAF V600E mutational status by PCR and NIS expression by immunohistochemistry.

Results

Sixteen patients were selected, 81.2% were girls. Average age of presentation was 11.8 years. Only one patient had previous radiation exposure. Most frequent symptom was cervical adenopathy with a mean time of 29.2 weeks before diagnosis. 93.7% underwent total thyroidectomy and lymphadenectomy. 62.5% were PTC combining both classic and follicular pattern. 6.25% cases had BRAFV600E mutation and 25% showed NIS focal reactivity.

Conclusions

We found greater female predominance, lower percentage of risk factors described and a high percentage of patients requiring aggressive surgical treatment. We consider important to contemplate thyroid cancer as a differential diagnosis of cervical lymph node enlargement in children. Diagnosis can be challenging in benign and indeterminate categories of the FNA cytology and biomolecular profiles such as BRAF and NIS could be determinant in guiding treatment. More studies with larger sample size, complete genetic analysis, evaluation to iodine response and long term follow up are required.


Corresponding author: Paula Castro MD, Pediatric Surgery Resident, Universidad Nacional de Colombia, Bogotá, Colombia, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: No funding organizations played a role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical statement: A retrospective descriptive study was submitted to the institutional ethics committee. After approval, a review of the medical records of selected patients was carried out and information related to presentation mode, background, diagnostic workup, surgical management and histology was extracted.

References

1. Galuppini, F, Vianello, F, Censi, S, Barollo, S, Bertazza, L, Carducci, S, et al. Differentiated thyroid carcinoma in paediatric age : genetic and clinical scenario. Front Endocrinol 2019;10:552.https://doi.org/10.3389/fendo.2019.00552.Suche in Google Scholar PubMed PubMed Central

2. Pizzo, PAPD. Principles and practice of paediatric oncology, 7th ed. Alphen aan den Rijn, Netherlands: Wolters Kluwer; 2016:1–12.Suche in Google Scholar

3. Cohen, M, Scheimberg, I. Essentials of surgical paediatric pathology Cambridge, United Kingdom: Cambridge University Press; 2014.Suche in Google Scholar

4. Gary, F, Waguespack, SG, Bauer, AJ, Angelos, P, Benvenga, S, Cerutti, JM, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 2015;25: 716–59. https://doi.org/10.1542/peds.2018-3063.Suche in Google Scholar PubMed

5. Pardo, C, Cendales, R. Cáncer en Colombia 2007–2011, 1st ed. Bogotá: Instituto Nacional de Cancerología; 2015 1.Suche in Google Scholar

6. Bravo, LE, Collazos, T, Collazos, P, García, LS, Correa, P. Colombia médica trends of cancer incidence and mortality in Cali, Colombia. 50 Years’ Ex 2012;43:246–55. https://doi.org/10.25100/cm.v43i4.1266.Suche in Google Scholar

7. Correa, C, Luengas, JP, Veintemilla, G. Experiencia en el diagnóstico y tratamiento de 38 casos de cáncer de tiroides en población pediátrica. Cir Cir 2019;87:7–11 https://doi.org/10.24875/CIRU.18000044.Suche in Google Scholar PubMed

8. Chan, CM, Young, J, Prager, J, Travers, S. Pediatric thyroid cancer [Internet]. Adv Pediatr 2017;64:171–90. https://doi.org/10.1016/j.yapd.2017.03.007.Suche in Google Scholar PubMed

9. Drozd, V, Fridman, M, Municipal, M, Clinical, O, Saenko, V. Chapter 6. Clinical aspects of pediatric thyroid cancer and follow-up of patients in Belarus following the Chernobyl accident. Thyroid cancer and nuclear accidents London, United Kingdom: Elsevier; 2017:59–65.10.1016/B978-0-12-812768-1.00006-XSuche in Google Scholar

10. Lin, K, Huang, C, Chao, T, Hseuh, C, Lin, K, Lin, S, et al. Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer. Pediatr Surg Int 2012;28:489–94. https://doi.org/10.1007/s00383-012-3054-1.Suche in Google Scholar PubMed

11. Acquaviva, G, Visani, M, Repaci, A, Rhoden, KJ, Biase, DD, Pession, A, et al. Molecular pathology of thyroid tumours of follicular cells : a review of genetic alterations and their clinicopathological relevance. Histopathology 2018;72:6–31. https://doi.org/10.1111/his.13380.Suche in Google Scholar PubMed

12. Picarsic, J, Buryk, M, Ozolek, J, Ranganathan, S, Monaco, S, Simons, J, et al. Molecular characterization of sporadic pediatric thyroid carcinoma with the DNA/RNA ThyroSeq v2 next-generation sequencing assay. Pediatr Dev Pathol 2016;19:115–22. https://doi.org/10.2350/15-07-1667-oa.1.Suche in Google Scholar PubMed PubMed Central

13. Poyrazoğlu, S, Bundak, R, Baş, F, Yeğen, G, Şanlı, Y, Darendeliler, F. Clinicopathological characteristics of papillary thyroid cancer in children with emphasis on pubertal status and association with brafv600e mutation. J Clin Res Pediatr Endocrinol 2017;9:185–93. https://doi.org/10.4274/jcrpe.3873.Suche in Google Scholar PubMed PubMed Central

14. Takami, H, Ozaki, O, Ito, K. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment [Internet]. Arch Surg 1996;131:676. https://doi.org/10.1001/archsurg.1996.01430180102023.Suche in Google Scholar PubMed

15. Callender, GG, Carling, T, Christison-lagay, E, Udelsman, R. Surgery for thyroid cancer. Endocrinol Metab Clin N Am 2014;43:443–58. https://doi.org/10.1016/j.ecl.2014.02.011.Suche in Google Scholar PubMed

16. Romero-Rojas, A, Cuervo-Martínez, J, Osorio-Arango, K, Olaya, N. Histological variants and prognostic factors of papillary thyroid carcinoma at the Colombian Instituto Nacional de Cancerología, 2006–2012. Biomedica 2015;35:429–36. https://doi.org/10.7705/biomedica.v35i3.2598.Suche in Google Scholar PubMed

17. Patel, A, Jhiang, S, Dogra, S, Terrell, R, Powers, PA, Fenton, C, et al. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents. Pediatr Res 2002;52:17–9. https://doi.org/10.1203/00006450-200211000-00021.Suche in Google Scholar PubMed

18. Lakshmanan, A, Scarberry, D, Shen, DH, Jhiang, SM. Modulation of sodium iodide symporter in thyroid cancer. Horm Canc 2014;5:363–73. https://doi.org/10.1007/s12672-014-0203-0.Suche in Google Scholar PubMed PubMed Central

19. Norlén, O, Charlton, A, Sarkis, LM, Henwood, T, Shun, A, Gill, AJ, et al. Risk of malignancy for each Bethesda class in pediatric thyroid nodules [Internet]. J Pediatr Surg 2015;50:1147–9. https://doi.org/10.1016/j.jpedsurg.2014.10.046.Suche in Google Scholar PubMed

20. Cooper, DS, Doherty, GM, Haugen, BR, Kloos, RT, Lee, SL, Mandel, SJ, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–214. https://doi.org/10.1089/thy.2009.0110.Suche in Google Scholar PubMed

21. Christison-Lagay, ER, Baertschiger, RM, Dinauer, C, Francis, GL, Malek, MM, Lautz, TB, et al. Pediatric differentiated thyroid carcinoma: an update from the APSA Cancer Committee. J Pediatr Surg 2020. Available from: https://doi.org/10.1016/j.jpedsurg.2020.05.003.Suche in Google Scholar PubMed

22. Schneider, AB, Sarne, DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metabol 2005;1:82–91. https://doi.org/10.1038/ncpendmet0022.Suche in Google Scholar PubMed

23. Lee, KA, Sharabiani, MTA, Tumino, D, Wadsley, J, Gill, V, Gerrard, G, et al. Differentiated thyroid cancer in children: a UK multicentre review and review of the literature [Internet]. Clin Oncol 2019;31:385–90. https://doi.org/10.1016/j.clon.2019.02.005.Suche in Google Scholar PubMed

24. Hodax, JK, Bowerman, K, Quintos, JB. Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations. J Pediatr Endocrinol Metab 2019;32:895–901. https://doi.org/10.1515/jpem-2018-0476.Suche in Google Scholar

25. Abi-raad, R, Prasad, M, Baldassari, R, Schofield, K, Callender, GG, Chhieng, D, et al. The value of negative diagnosis in thyroid fine-needle aspiration : a retrospective study with histologic follow-up. Endocr Pathol 2018;29:269–75. https://doi.org/10.1007/s12022-018-9536-5.Suche in Google Scholar

26. Sclabas, GM, Staerkel, GA, Shapiro, SE, Fornage, BD, Sherman, SI, Vassillopoulou-Sellin, R, et al. Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg 2003;186:702–10. https://doi.org/10.1016/j.amjsurg.2003.08.015.Suche in Google Scholar

27. Kazaure, HS, Roman, SA, Sosa, JA. Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival. Cancer 2012;118:3260–7. https://doi.org/10.1002/cncr.26638.Suche in Google Scholar

28. Rijhwani, A, Satish, GN. Insular carcinoma of the thyroid in a 10-year-old child. J Pediatr Surg 2003;38:1083–5. https://doi.org/10.1016/s0022-3468(03)00198-2.Suche in Google Scholar

29. Lo, CY, Lam, KY, Wan, KY. Insular thyroid carcinoma in adolescents. Eur J Surg 2000;166:585–8. https://doi.org/10.1080/110241500750008718.Suche in Google Scholar PubMed

30. Isabel, M, Cordioli, CV, Moraes, L, Cury, AN, Cerutti, JM. Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma ? Endocr Relat Canc 2014;6:311–24. https://doi.org/10.1530/erc-15-0381.Suche in Google Scholar

31. Henke, LE, Perkins, SM, Pfeifer, JD, Ma, C, Chen, Y, Dewees, T, et al. BRAF V600E mutational status in pediatric thyroid cancer. Pediatr Blood Canc 2014;61:1168–72. https://doi.org/10.1002/pbc.24935.Suche in Google Scholar PubMed

32. Givens, DJ, Buchmann, LO, Agarwal, AM, Grimmer, JF, Hunt, JP. BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma. Laryngoscope 2014;124:389–93. https://doi.org/10.1002/lary.24668.Suche in Google Scholar PubMed

33. Lima, J, Trovisco, TOR, Soares, P, Ma, V, Magalha, O, Lima, J, et al. BRAF mutations are not a major event in post- Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab 2004;89:4267–71. https://doi.org/10.1210/jc.2003-032224.Suche in Google Scholar PubMed

Received: 2020-04-17
Accepted: 2020-08-28
Published Online: 2020-10-08
Published in Print: 2020-11-26

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. The influence of growth hormone therapy on the cardiovascular system in Turner syndrome
  4. Original Articles
  5. Clinical utility of urinary gonadotrophins in hypergonadotrophic states as Turner syndrome
  6. Sclerostin and osteoprotegerin: new markers of chronic kidney disease mediated mineral and bone disease in children
  7. Monthly intravenous alendronate treatment can maintain bone strength in osteogenesis imperfecta patients following cyclical pamidronate treatment
  8. Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes
  9. Frequency of thyroid dysfunction in pediatric patients with congenital heart disease exposed to iodinated contrast media – a long-term observational study
  10. Effect of growth hormone therapy on thyroid function in isolated growth hormone deficient and short small for gestational age children: a two-year study, including on assessment of the usefulness of the thyrotropin-releasing hormone (TRH) stimulation test
  11. Clinical relevance of T lymphocyte subsets in pediatric Graves’ disease
  12. Long-term follow-up of differentiated thyroid carcinoma in children and adolescents
  13. A quality improvement project for managing hypocalcemia after pediatric total thyroidectomy
  14. Pubertal development and adult height in patients with congenital hypothyroidism detected by neonatal screening in southern Brazil
  15. Clinical characteristics, surgical approach, BRAFV600E mutation and sodium iodine symporter expression in pediatric patients with thyroid carcinoma
  16. BRAFV600E and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation
  17. Case Reports
  18. Pseudohypoparathyroidism type 1B (PHP1B), a rare disorder encountered in adolescence
  19. Impaired glucose homeostasis and a novel HLCS pathogenic variant in holocarboxylase synthetase deficiency: a report of two cases and brief review
  20. Transcobalamin II deficiency in twins with a novel variant in the TCN2 gene: case report and review of literature
  21. Aldosterone deficiency with a hormone profile mimicking pseudohypoaldosteronism
  22. Non-classical lipoid adrenal hyperplasia presenting as hypoglycemic seizures
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0201/html?lang=de
Button zum nach oben scrollen